Wolfgang Miesbach – Targeting VEGF to Stop GI Bleeding: Systemic Bevacizumab
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
“Targeting VEGF to Stop GI Bleeding: Systemic Bevacizumab
Exciting data from ASH25! Dr. Nardeen Ayad presented compelling long-term results on systemic bevacizumab—a monoclonal antibody targeting VEGF-A to inhibit abnormal angiogenesis—for severe, chronic GI bleeding.

The Cohort (N=23):
The study followed 23 patients for up to 4.2 years.
These were complex, real-world cases:
Advanced Age: Median 78 years (range 42–90).
High Comorbidity: 56% Heart Failure, 26% Aortic Stenosis, 74% Hypertension.
Complex Etiology: 40% Idiopathic Angiodysplasia, 30% Type 2 VWD / Acquired VWS, 30% Chronic Liver Disease.

Clinical Impact:
The primary endpoint was the Hematologic Support Score (HSS)—a composite metric calculated as (Units RBCs Transfused) + (mg Elemental Iron Infused / 250).
– HSS Score: Dropped from 14.2 (baseline) to 0.6 (1 year) (P<0.001).
– Transfusions: Median RBC units went from 8 (pre-treatment) to ZERO.
– Utilization: ER visits/admissions cut significantly (3.5 → 1 per year).
Safety:
No thromboembolic events recorded despite high CV risk.
By targeting the underlying vascular pathology, bevacizumab is proving to be a safe, effective long-term option for older, comorbid patients who have exhausted standard therapies.
Is anti-angiogenic therapy now part of our algorithm for refractory angiodysplasia?”
Read more from Wolfgang Miesbach on Hemostasis Today.
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer
-
Nov 8, 2026, 05:24Recognising Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding – RPTH Journal
-
Nov 8, 2026, 05:11WFH CCS 2027 Abstract Submission Now Open – World Federation of Hemophilia